Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06470659 · ClinicalTrials.gov registry record · NA

Medications With or Without WeightWatchers

A NA study of Obesity and Overweight, sponsored by Michelle Cardel, PhD, MS, RD.

Completed
Registry status
NA
Development phase
101
Enrollment target
1
Study location

NCT06470659: Completed NA study of Obesity and Overweight, sponsored by Michelle Cardel, PhD, MS, RD.

NCT06470659 is a NA study of Obesity and Overweight that has completed, run by Michelle Cardel, PhD, MS, RD. The registered enrollment target is 101 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06470659, a NA study of Obesity and Overweight, has completed, sponsored by Michelle Cardel, PhD, MS, RD.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target
1
Study location

Study Summary

The study compares the effectiveness of adults living with overweight or obesity taking weight management medications alone vs taking them with behavioral and lifestyle support. The primary outcome is percent body weight lost at 12-weeks.

Primary Outcome

Measurement of weight using a bluetooth body weight scale

Conditions Studied

Interventions

  • BEHAVIORAL WW Clinic

Study Locations (1)

New York

  • WW International, Inc - New York

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2024-06-17
Est. Completion 2025-01-28
Phase NA
Michelle Cardel, PhD, MS, RD

1 total trials

What the finished NCT06470659 record still lists

NCT06470659 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which WW Clinic is the first listed.

NCT06470659 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06470659 about?

NCT06470659 is a clinical study titled "Medications With or Without WeightWatchers". The study compares the effectiveness of adults living with overweight or obesity taking weight management medications alone vs taking them with behavioral and lifestyle support. The primary outcome is percent body weight lost at 12-weeks.

What is the current status of trial NCT06470659?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2024-06-17. Estimated completion is 2025-01-28.

What conditions does trial NCT06470659 study?

This clinical trial studies the following conditions: Obesity, Overweight.

What interventions are being tested in trial NCT06470659?

The interventions under investigation include: WW Clinic (BEHAVIORAL).

Who is sponsoring clinical trial NCT06470659?

This trial is sponsored by Michelle Cardel, PhD, MS, RD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06470659 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06470659's enrollment target sits among peer trials

101 473rd of 1053 higher than 577 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04033497 · 101 participants · NA

    Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

  • NCT05111574 · 101 participants · Phase 2

    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

  • NCT05984680 · 101 participants

    COPD Care Pathway Among Patients With Cancer

  • NCT06266299 · 101 participants · Phase 1

    A Study of KK2269 in Adult Participants With Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06470659, the US trial registry maintained by the National Library of Medicine. NCT06470659 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.